Insights into new mechanisms and models of cancer stem cell multidrug resistance

Y Garcia-Mayea, C Mir, F Masson, R Paciucci… - Seminars in cancer …, 2020 - Elsevier
The acquisition of genetic alterations, clonal evolution, and the tumor microenvironment
promote cancer progression, metastasis and therapy resistance. These events correspond …

[HTML][HTML] Common stemness regulators of embryonic and cancer stem cells

C Hadjimichael, K Chanoumidou… - World journal of stem …, 2015 - ncbi.nlm.nih.gov
Pluripotency of embryonic stem cells (ESCs) and induced pluripotent stem cells is regulated
by a well characterized gene transcription circuitry. The circuitry is assembled by ESC …

Histone deacetylase inhibitors: an attractive therapeutic strategy against breast cancer

C Damaskos, S Valsami, M Kontos… - Anticancer …, 2017 - ar.iiarjournals.org
With a lifetime risk estimated to be one in eight in industrialized countries, breast cancer is
the most frequent type of cancer among women worldwide. Patients are often treated with …

Epigenetic modifications and head and neck cancer: implications for tumor progression and resistance to therapy

RM Castilho, CH Squarize, LO Almeida - International journal of …, 2017 - mdpi.com
Head and neck squamous carcinoma (HNSCC) is the sixth most prevalent cancer and one
of the most aggressive malignancies worldwide. Despite continuous efforts to identify …

Epigenetic modifications in head and neck cancer

J Gaździcka, K Gołąbek, JK Strzelczyk… - Biochemical …, 2020 - Springer
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common human
malignancy in the world, with high mortality and poor prognosis for patients. Among the risk …

Cytokines, breast cancer stem cells (BCSCs) and chemoresistance

W Chen, Y Qin, S Liu - Clinical and translational medicine, 2018 - Springer
Chemotherapy resistance of breast cancer poses a great challenge to the survival of
patients. During breast cancer treatment, the development of intrinsic and acquired drug …

[HTML][HTML] NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)

LO Almeida, AC Abrahao, LK Rosselli-Murai… - FEBS open bio, 2014 - Elsevier
Cisplatin-based chemotherapy is the standard treatment of choice for head and neck
squamous cell carcinoma (HNSCC). The efficiency of platinum-based therapies is directly …

Epigenetics and its role in periodontal diseases: a state‐of‐the‐art review

L Larsson, RM Castilho… - Journal of …, 2015 - Wiley Online Library
The immune response to oral bacteria and the subsequent activation of inflammatory
signaling is not only dependent on genetic factors. The importance of so‐called epigenetic …

Advances in the treatment of mucoepidermoid carcinoma

S Sama, T Komiya, AK Guddati - World Journal of Oncology, 2021 - pmc.ncbi.nlm.nih.gov
Mucoepidermoid carcinoma (MEC) represents 10-15% of salivary neoplasms. Due to their
low incidence, it is challenging to conduct clinical trials and develop treatment guidelines …

Epigenetic regulation of endothelial-to-mesenchymal transition in chronic heart disease: histone modifications, DNA methylation, and noncoding RNAs

MS Hulshoff, X Xu, G Krenning… - … thrombosis, and vascular …, 2018 - Am Heart Assoc
Endothelial-to-mesenchymal transition (EndMT) is a process in which endothelial cells lose
their properties and transform into fibroblast-like cells. This transition process contributes to …